Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Leukemia ; 29(5): 1177-85, 2015 May.
Article in English | MEDLINE | ID: mdl-25428260

ABSTRACT

To characterise the genetics of splenic marginal zone lymphoma (SMZL), we performed whole exome sequencing of 16 cases and identified novel recurrent inactivating mutations in Kruppel-like factor 2 (KLF2), a gene whose deficiency was previously shown to cause splenic marginal zone hyperplasia in mice. KLF2 mutation was found in 40 (42%) of 96 SMZLs, but rarely in other B-cell lymphomas. The majority of KLF2 mutations were frameshift indels or nonsense changes, with missense mutations clustered in the C-terminal zinc finger domains. Functional assays showed that these mutations inactivated the ability of KLF2 to suppress NF-κB activation by TLR, BCR, BAFFR and TNFR signalling. Further extensive investigations revealed common and distinct genetic changes between SMZL with and without KLF2 mutation. IGHV1-2 rearrangement and 7q deletion were primarily seen in SMZL with KLF2 mutation, while MYD88 and TP53 mutations were nearly exclusively found in those without KLF2 mutation. NOTCH2, TRAF3, TNFAIP3 and CARD11 mutations were observed in SMZL both with and without KLF2 mutation. Taken together, KLF2 mutation is the most common genetic change in SMZL and identifies a subset with a distinct genotype characterised by multi-genetic changes. These different genetic changes may deregulate various signalling pathways and generate cooperative oncogenic properties, thereby contributing to lymphomagenesis.


Subject(s)
Kruppel-Like Transcription Factors/genetics , Lymphoma, B-Cell, Marginal Zone/genetics , Mutation , Splenic Neoplasms/genetics , Biopsy , CARD Signaling Adaptor Proteins/metabolism , DNA-Binding Proteins/metabolism , Exome , Frameshift Mutation , Gene Rearrangement, B-Lymphocyte, Heavy Chain , Genetic Variation , Genotype , Guanylate Cyclase/metabolism , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Lymphoma/metabolism , Lymphoma, B-Cell, Marginal Zone/diagnosis , Mutation, Missense , Nuclear Proteins/metabolism , Polymerase Chain Reaction , Receptor, Notch2/metabolism , Recurrence , Sequence Analysis, DNA , Signal Transduction , Splenic Neoplasms/diagnosis , Tumor Necrosis Factor alpha-Induced Protein 3
2.
Oncogene ; 30(32): 3537-48, 2011 Aug 11.
Article in English | MEDLINE | ID: mdl-21423202

ABSTRACT

Glioblastoma multiforme is one of the most devastating cancers and presents unique challenges to therapy because of its aggressive behavior. Cancer-initiating or progenitor cells have been described to be the only cell population with tumorigenic capacity in glioblastoma. Therefore, effective therapeutic strategies targeting these cells or the early precursors may be beneficial. We have established different cultures of glioblastoma-initiating cells (GICs) derived from surgical specimens and found that, after induction of differentiation, the NFκB transcriptional pathway was activated, as determined by analyzing key proteins such as p65 and IκB and the upregulation of a number of target genes. We also showed that blockade of nuclear factor (NF)κB signaling in differentiating GICs by different genetic strategies or treatment with small-molecule inhibitors, promoted replication arrest and senescence. This effect was partly mediated by reduced levels of the NFκB target gene cyclin D1, because its downregulation by RNA interference reproduced a similar phenotype. Furthermore, these results were confirmed in a xenograft model. Intravenous treatment of immunodeficient mice bearing human GIC-derived tumors with a novel small-molecule inhibitor of the NFκB pathway induced senescence of tumor cells but no ultrastructural alterations of the brain parenchyma were detected. These findings reveal that activation of NFκB may keep differentiating GICs from acquiring a mature postmitotic phenotype, thus allowing cell proliferation, and support the rationale for therapeutic strategies aimed to promote premature senescence of differentiating GICs by blocking key factors within the NFκB pathway.


Subject(s)
Cellular Senescence/genetics , Glioblastoma/genetics , NF-kappa B/genetics , Signal Transduction/genetics , Animals , Blotting, Western , Carbazoles/pharmacology , Cell Differentiation/genetics , Cell Proliferation/drug effects , Cellular Senescence/drug effects , Cyclin D1/genetics , Cyclin D1/metabolism , Female , Gene Expression Profiling , Glioblastoma/drug therapy , Glioblastoma/pathology , Glycosides/pharmacology , Humans , I-kappa B Kinase/antagonists & inhibitors , I-kappa B Kinase/genetics , I-kappa B Kinase/metabolism , I-kappa B Proteins/genetics , I-kappa B Proteins/metabolism , Mice , Mice, Inbred BALB C , Mice, Knockout , NF-kappa B/antagonists & inhibitors , NF-kappa B/metabolism , Neural Stem Cells/drug effects , Neural Stem Cells/metabolism , Neural Stem Cells/pathology , Nitriles/pharmacology , Oligonucleotide Array Sequence Analysis , Protein Kinase Inhibitors/pharmacology , RNA Interference , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Sulfones/pharmacology , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
3.
Biochem Soc Trans ; 34(Pt 1): 108-10, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16417495

ABSTRACT

Nitrate respiration by the N(2)-fixing symbiotic bacteria Bradyrhizobium japonicum USDA110 is mediated by a Nap (periplasmic nitrate reductase) encoded by the napEDABC genes. Expression of a transcriptional fusion of the nap promoter region to the reporter gene lacZ, P(napE)-lacZ, was very low in aerobically grown cells of USDA110, but expression was induced approx. 3-fold when the cells were cultured under microaerobic conditions, and 12-fold when nitrate was added to the microaerobic incubation medium. The P(napE)-lacZ fusion was not expressed in the fixL 7403, fixJ 7360 and fixK(2) 9043 mutant strains. Microaerobic induction of the P(napE)-lacZ fusion was retained in the nnrR 8678 mutant, but no increase in beta-galactosidase activity was observed upon nitrate addition. Western-blot and Methyl Viologen-dependent nitrate reductase activity assays showed that synthesis and activity of the catalytic NapA subunit in USDA110 was similar to that in the napC 0906 and nirK GRK308 mutant strains incubated microaerobically with nitrate. These results suggest that nitrate and nitrite, which are not reduced by the napC 0906 and nirK GRK308 mutant cells respectively, induced the synthesis and activity of NapA; conversely, formation of endogenous NO was not required for induction of Nap expression.


Subject(s)
Bacterial Proteins/metabolism , Bradyrhizobium/genetics , Gene Expression Regulation, Bacterial , Hemeproteins/metabolism , Nitrate Reductases/genetics , Trans-Activators/metabolism , Bacterial Proteins/genetics , Bradyrhizobium/enzymology , Hemeproteins/genetics , Histidine Kinase , Nitrate Reductases/metabolism , Nitrates/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Signal Transduction/physiology , Trans-Activators/genetics , beta-Galactosidase/genetics , beta-Galactosidase/metabolism
4.
Biochem Soc Trans ; 33(Pt 1): 141-4, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15667287

ABSTRACT

Denitrification is an alternative form of respiration in which bacteria sequentially reduce nitrate or nitrite to nitrogen gas by the intermediates nitric oxide and nitrous oxide when oxygen concentrations are limiting. In Bradyrhizobium japonicum, the N(2)-fixing microsymbiont of soya beans, denitrification depends on the napEDABC, nirK, norCBQD, and nosRZDFYLX gene clusters encoding nitrate-, nitrite-, nitric oxide- and nitrous oxide-reductase respectively. Mutational analysis of the B. japonicum nap genes has demonstrated that the periplasmic nitrate reductase is the only enzyme responsible for nitrate respiration in this bacterium. Regulatory studies using transcriptional lacZ fusions to the nirK, norCBQD and nosRZDFYLX promoter region indicated that microaerobic induction of these promoters is dependent on the fixLJ and fixK(2) genes whose products form the FixLJ-FixK(2) regulatory cascade. Besides FixK(2), another protein, nitrite and nitric oxide respiratory regulator, has been shown to be required for N-oxide regulation of the B. japonicum nirK and norCBQD genes. Thus nitrite and nitric oxide respiratory regulator adds to the FixLJ-FixK(2) cascade an additional control level which integrates the N-oxide signal that is critical for maximal induction of the B. japonicum denitrification genes. However, the identity of the signalling molecule and the sensing mechanism remains unknown.


Subject(s)
Bradyrhizobium/metabolism , Nitrites/metabolism , Nitrogen Fixation , Symbiosis , Bradyrhizobium/enzymology , Bradyrhizobium/genetics , Genes, Bacterial , Nitrite Reductases/genetics , Oxidoreductases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...